5 Key Takeaways

• 1

  Diabetic retinopathy screening is suboptimal globally, with US adherence rates as low as 20% and significant disparities in access.

• 2

  A study from Johns Hopkins Medicine shows that autonomous AI can improve screening rates and access to specialist eye care.

• 3

  Patients screened via AI were more likely to attend eye care specialists, especially African-American patients who are historically underserved.

• 4

  Point-of-care AI screening integrates into primary care, providing immediate results and actionable referrals to enhance patient follow-up.

• 5

  Improving screening alone is insufficient; downstream access to ophthalmic care is crucial for better diabetic retinopathy outcomes.